PKCdelta KD (K378R)
(Plasmid
#260717)
-
PurposeDOX inducible expression of PKCdelta KD K378R (FLAG-tagged). KD: kinase-dead
-
Depositing Lab
-
Depositing OrganizationDana-Farber Cancer Institute
Located in the United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 260717 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepINDUCER21-puro_Gateway-3xFLAG
-
Backbone manufacturerMichael Wehr (Addgene Plasmid #172981)
- Backbone size w/o insert (bp) 10480
- Total vector size (bp) 12508
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePRKCD KD (K378R)
-
Alt namePKCdelta Kinase Dead (K378R)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2025
-
MutationK378R
-
GenBank IDNP_001303256.1
-
Entrez GenePRKCD (a.k.a. ALPS3, CVID9, MAY1, PKCD, nPKC-delta)
- Promoter tetracycline response element
-
Tag
/ Fusion Protein
- FLAG (C terminal on backbone)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer ATTB1
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2025.08.27.671140 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PKCdelta KD (K378R) was a gift from William Kaelin (Addgene plasmid # 260717 ; http://n2t.net/addgene:260717 ; RRID:Addgene_260717) -
For your References section:
Positive selection screen identifies natural product beta-catenin inactivators. Boudreau MW, Freire VF, Corbett SC, Martinez-Fructuoso L, Shenoy SR, Yu W, Kumar R, Thornburg CC, Akee RK, Peyser BD, Jiang Q, Splaine J, Pfaff JL, Yu D, Chandler BC, Abeja DM, Donovan KA, Che J, Lampson BL, Cooke M, Kazanietz MG, Szajner P, Smith JA, Koduri V, Grkovic T, O'Keefe BR, Kaelin WG Jr. Proc Natl Acad Sci U S A. 2026 Sep 29;123(39):e2625189123. doi: 10.1073/pnas.2625189123. Epub 2026 Sep 25. 10.1073/pnas.2625189123 PubMed 42789292